サワイグループホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/02/08 | 4,510 | 4,540 | 4,505 | 4,510 | +5 | +0.1% | 46,800 |
| 2022/02/07 | 4,470 | 4,510 | 4,450 | 4,505 | +15 | +0.3% | 49,300 |
| 2022/02/04 | 4,465 | 4,510 | 4,440 | 4,490 | +45 | +1% | 80,500 |
| 2022/02/03 | 4,385 | 4,475 | 4,375 | 4,445 | +55 | +1.3% | 68,700 |
| 2022/02/02 | 4,295 | 4,395 | 4,290 | 4,390 | +90 | +2.1% | 114,300 |
| 2022/02/01 | 4,230 | 4,320 | 4,230 | 4,300 | -35 | -0.8% | 123,000 |
| 2022/01/31 | 4,340 | 4,360 | 4,305 | 4,335 | +5 | +0.1% | 110,400 |
| 2022/01/28 | 4,360 | 4,385 | 4,320 | 4,330 | +5 | +0.1% | 66,800 |
| 2022/01/27 | 4,375 | 4,405 | 4,305 | 4,325 | -40 | -0.9% | 74,700 |
| 2022/01/26 | 4,410 | 4,420 | 4,360 | 4,365 | -45 | -1% | 51,800 |
| 2022/01/25 | 4,360 | 4,415 | 4,345 | 4,410 | -10 | -0.2% | 47,100 |
| 2022/01/24 | 4,355 | 4,420 | 4,335 | 4,420 | +55 | +1.3% | 85,300 |
| 2022/01/21 | 4,280 | 4,375 | 4,260 | 4,365 | +50 | +1.2% | 81,200 |
| 2022/01/20 | 4,280 | 4,360 | 4,280 | 4,315 | -5 | -0.1% | 102,100 |
| 2022/01/19 | 4,345 | 4,360 | 4,295 | 4,320 | -25 | -0.6% | 91,800 |
| 2022/01/18 | 4,415 | 4,430 | 4,340 | 4,345 | -70 | -1.6% | 85,300 |
| 2022/01/17 | 4,400 | 4,440 | 4,385 | 4,415 | +75 | +1.7% | 60,500 |
| 2022/01/14 | 4,340 | 4,360 | 4,305 | 4,340 | -60 | -1.4% | 123,500 |
| 2022/01/13 | 4,470 | 4,470 | 4,395 | 4,400 | -80 | -1.8% | 87,900 |
| 2022/01/12 | 4,440 | 4,495 | 4,440 | 4,480 | +25 | +0.6% | 75,900 |
| 2022/01/11 | 4,450 | 4,520 | 4,400 | 4,455 | -25 | -0.6% | 122,400 |
| 2022/01/07 | 4,455 | 4,510 | 4,455 | 4,480 | +15 | +0.3% | 57,700 |
| 2022/01/06 | 4,490 | 4,505 | 4,450 | 4,465 | -25 | -0.6% | 109,700 |
| 2022/01/05 | 4,490 | 4,505 | 4,450 | 4,490 | +35 | +0.8% | 75,400 |
| 2022/01/04 | 4,420 | 4,460 | 4,380 | 4,455 | +60 | +1.4% | 81,500 |
| 2021/12/30 | 4,450 | 4,450 | 4,380 | 4,395 | ±0 | ±0% | 69,300 |
| 2021/12/29 | 4,325 | 4,405 | 4,325 | 4,395 | +70 | +1.6% | 65,900 |
| 2021/12/28 | 4,290 | 4,340 | 4,270 | 4,325 | +55 | +1.3% | 88,400 |
| 2021/12/27 | 4,305 | 4,305 | 4,225 | 4,270 | -35 | -0.8% | 95,900 |
| 2021/12/24 | 4,325 | 4,335 | 4,290 | 4,305 | -55 | -1.3% | 87,700 |
| 2021/12/23 | 4,370 | 4,380 | 4,310 | 4,360 | ±0 | ±0% | 68,300 |
| 2021/12/22 | 4,410 | 4,415 | 4,350 | 4,360 | -60 | -1.4% | 74,000 |
| 2021/12/21 | 4,480 | 4,480 | 4,405 | 4,420 | -20 | -0.5% | 70,600 |
| 2021/12/20 | 4,475 | 4,490 | 4,425 | 4,440 | -75 | -1.7% | 64,600 |
| 2021/12/17 | 4,515 | 4,545 | 4,475 | 4,515 | ±0 | ±0% | 134,300 |
| 2021/12/16 | 4,500 | 4,540 | 4,465 | 4,515 | -10 | -0.2% | 114,600 |
| 2021/12/15 | 4,515 | 4,545 | 4,500 | 4,525 | +10 | +0.2% | 66,000 |
| 2021/12/14 | 4,510 | 4,545 | 4,495 | 4,515 | +20 | +0.4% | 103,800 |
| 2021/12/13 | 4,510 | 4,540 | 4,470 | 4,495 | +10 | +0.2% | 86,700 |
| 2021/12/10 | 4,550 | 4,555 | 4,450 | 4,485 | -15 | -0.3% | 112,200 |
| 2021/12/09 | 4,485 | 4,500 | 4,445 | 4,500 | -5 | -0.1% | 102,300 |
| 2021/12/08 | 4,495 | 4,515 | 4,475 | 4,505 | +45 | +1% | 96,200 |
| 2021/12/07 | 4,380 | 4,470 | 4,365 | 4,460 | +100 | +2.3% | 140,800 |
| 2021/12/06 | 4,315 | 4,385 | 4,295 | 4,360 | +35 | +0.8% | 197,600 |
| 2021/12/03 | 4,285 | 4,335 | 4,225 | 4,325 | +45 | +1.1% | 166,200 |
| 2021/12/02 | 4,265 | 4,345 | 4,255 | 4,280 | ±0 | ±0% | 116,100 |
| 2021/12/01 | 4,250 | 4,340 | 4,250 | 4,280 | +80 | +1.9% | 124,000 |
| 2021/11/30 | 4,285 | 4,325 | 4,190 | 4,200 | -65 | -1.5% | 191,300 |
| 2021/11/29 | 4,320 | 4,330 | 4,250 | 4,265 | -75 | -1.7% | 130,500 |
| 2021/11/26 | 4,445 | 4,445 | 4,315 | 4,340 | -130 | -2.9% | 136,500 |
801～
850
件表示中 / 1010件
類似銘柄と比較する
現在ご覧いただいている「サワイＧＨＤ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| サワイＧＨＤ | 176,100円 | +5.9% | +24.5% | 3.12% | 11.69倍 | 1.10倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| 日本新薬 | 341,500円 | +8.0% | -15.3% | 3.63% | 9.59倍 | 0.93倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ペプチド | 171,800円 | +5.0% | +1.5% | 0.00% | 14.69倍 | 3.91倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| キッセイ薬 | 389,000円 | +3.6% | +6.1% | 3.08% | 13.11倍 | 0.77倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 鳥居薬 | 634,000円 | +7.1% | -35.0% | 0.00% | 52.42倍 | 1.46倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
市場注目の銘柄
チャート関連のコラム
